Skip to main content
. 2020 Dec 17;9(3):648–658. doi: 10.1016/j.gendis.2020.12.005

Table 1.

Prognostic molecular markers of breast cancer.

Prognostic molecular markers Prognosis Detection method Potential medical use References
ER ER-positive breast cancer Patients have better survival rate than patients with ER-negative cancer. IHC Yes 11,32,52
Her2 Her2 positive breast cancers are more aggressive and have a poor prognosis compared to Her2/neu-negative tumors. IHC and FISH Yes 8,9,11,32
PR PR-positive breast cancer Patients have better survival rate than patients with PR-negative cancer. IHC Yes 11,13,32